Yatharth Hospital Q1 Results: Earnings call scheduled for Aug 11
Yatharth Hospital & Trauma Care Services Ltd announced its Q1FY27 earnings call date as August 11, 2026. The session will cover standalone and consolidated results for the quarter ended June 30, 2026, featuring commentary from top management including CEO Amit Kumar Singh and CFO Pankaj Prabhakar.
*this image is generated using AI for illustrative purposes only.
Yatharth Hospital & Trauma Care Services Limited will host an earnings conference call on August 11, 2026, at 11:00 AM IST to discuss its unaudited financial results for the first quarter ended June 30, 2026. The announcement, filed with the National Stock Exchange of India Limited and BSE Limited on August 06, 2026, provides investors with the schedule to review the company’s standalone and consolidated performance for Q1FY27.
The conference call is being organized in compliance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Ritesh Mishra, Company Secretary & Compliance Officer, and includes the company’s ISIN code INE0JO301016 for both exchanges. The full transcript and related information will be hosted on the company’s investor relations website.
Management Participation
A senior leadership team will represent Yatharth Hospital during the discussion, providing insights into operational metrics and financial outcomes. The participating executives include:
| Executive | Designation |
|---|---|
| Yatharth Tyagi | Whole-Time Director |
| Amit Kumar Singh | Group Chief Executive Officer |
| Nitin Gupta | President, Finance and Group Chief Operating Officer |
| Pankaj Prabhakar | Group Chief Financial Officer |
| Ashutosh Kumar Jha | Group Chief Strategy, M&A and Investor Relations |
| Sonu Goyal | Group Chief Financial Controller |
Dial-In Details
Investors and analysts can participate in the call via multiple international dial-in numbers managed by Systematix Institutional Equities. The primary dial-in number for India is +91 22 6280 1297, with a secondary number available at +91 22 7115 8198.
International participants may use the following toll-free numbers:
| Location | Dial Number |
|---|---|
| USA | 1 866 746 2133 |
| UK | 0 808 101 1573 |
| Singapore | 800 101 2045 |
| Hong Kong | 800 964 448 |
Participants are advised to register for DiamondPass™ via the provided link to connect without waiting for an operator. For further assistance, investors may contact Vishal Manchanda, Equity Research Analyst, or Mrunal Pawar, Senior VP & Group Head - Corporate Access & Corporate Communication.
Historical Stock Returns for Yatharth Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.53% | +4.63% | +3.43% | +34.61% | +27.24% | +161.03% |
How will Yatharth Hospital's Q1FY27 performance reflect the impact of recent regulatory changes in India's healthcare sector on its operational margins?
What specific M&A strategies did Ashutosh Kumar Jha outline during the call to accelerate market share in tier-2 and tier-3 cities for FY27?
To what extent will rising input costs for medical supplies and pharmaceuticals affect the company's consolidated EBITDA growth trajectory in the upcoming quarters?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
